packageLeniolisib

leniolisib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Leniolisib is used to treat primary immunodeficiency diseases. It is authorised in the European Union as an immunomodulating medicine.

Summary written by glm-5.3-flash from Wikidata Q27282602 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:leniolisib
ATC codes:L03AX22
DrugBank:DB16217
PubChem CID:57495353
Wikidata:Q27282602
formula:C21H25F3N6O2
molar mass:450.465 g/mol (PubChem CID 57495353)
logP:2.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown